Immunohistochemical determination of p53 overexpression

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Urological research

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/BF00942045PMID 9079754
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• P53 accumulation in precursor lesions and early stages of bladder cancer

  2004cited by this paper
• Prevalence and Clinical Significance of Her-2/neu, p53 and Rb Expression in Primary Superficial Bladder Cancer

  1996cited by this paper
• Overexpression of p53 protein and its significance for recurrent progressive bladder tumours.

  1996cited by this paper
• Pharmacodynamics of doxorubicin in human bladder tumors.

  1996cited by this paper
• Prevalence and clinical significance of HER/2neu, p53 and Rb expression in primary superficial bladder cancer.

  1996cited by this paper
• Prognostic value of p53 nuclear overexpression in patients with invasive bladder cancer treated with neoadjuvant MVAC.

  1995cited by this paper
• Evaluation of overexpression of p53 tumor suppressor protein in superficial and invasive transitional cell bladder cancer: comparison with DNA ploidy.

  1995cited by this paper
• Prognostic value of p53 nuclear overexpression in patients with invasive bladder cancer treated with neoadjuvant MVAC.

  1995cited by this paper
• p53 immunohistochemistry as an independent prognostic factor for superficial transitional cell carcinoma of the bladder.

  1995cited by this paper
• Accumulation of nuclear p53 and tumor progression in bladder cancer.

  1994cited by this paper
• P53 expression, ploidy and progression in pT1 transitional cell carcinoma of the bladder.

  1994cited by this paper
• Association of P53 nuclear overexpression and tumor progression in carcinoma in situ of the bladder.

  1994cited by this paper
• An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms

  1994cited by this paper
• Immunohistological expression of p53 in primary pT1 transitional cell bladder cancer in relation to tumour progression.

  1994cited by this paper
• Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.

  1994cited by this paper
• Clinical implications of the p53 tumor-suppressor gene.

  1993cited by this paper
• p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer.

  1993cited by this paper
• Molecular Genetic Alterations of Chromosome 17 and p53 Nuclear Overexpression in Human Bladder Cancer

  1993cited by this paper
• Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: a marker for disease progression.

  1993cited by this paper
• The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation.

  1992cited by this paper
• The p53 tumor-suppressor gene.

  1992cited by this paper
• p53, guardian of the genome

  1992cited by this paper
• Cancer. p53, guardian of the genome.

  1992cited by this paper
• Tumor suppressor genes.

  1991cited by this paper
• The p53 tumour suppressor gene

  1991cited by this paper

• A study on immunohistochemical expression of HER2/Neu and p63 and its association with grade and invasiveness in case of bladder carcinoma

  2024cites this paper
• Association of smoking, p53 and Ki-67 immunomarkers with bladder neoplasms in tribal region of India

  2022cites this paper
• Prognostic markers in invasive bladder cancer: FGFR3 mutation status versus P53 and KI-67 expression: a multi-center, multi-laboratory analysis in 1058 radical cystectomy patients.

  2021cites this paper
• Assessment of p53 mutations, expression and prognosis in bladder cancer patients from Jordan: Identification of novel deletion mutations in the DNA-binding domain

  2017cites this paper
• The Role of CK20, p53 and p63 in Differentiation of Some Urothelial Lesions of Urinary Bladder, Immunohistochemical Study

  2014cites this paper
• Biomarkers in bladder cancer: translational and clinical implications.

  2014cites this paper
• Immunohistochemical expression of p63, p53 in urinary bladder carcinoma.

  2013cites this paper
• Autologous Immunotherapy as a Novel Treatment for Bladder Cancer

  2013cites this paper
• Tissue‐based Biomarkers

  2012cites this paper
• Is it safe to utilize in vitro reconstituted human oral epithelium? An oncogenetic pathway study

  2012cites this paper
• Quadruple Primary Malignancies of Liver, Bladder, Lung and Stomach in One Patient

  2010cites this paper
• Quadruple primary malignancies of liver, bladder, lung and stomach in one patient.

  2010cites this paper
• p53 immunohistochemistry in bladder cancer--a new approach to an old question.

  2010cites this paper
• Immunohistochemical positive stained p53 protein in bladder transitional cell carcinoma.

  2009cites this paper
• Proteomics and genomics of urinary bladder cancer

  2008cites this paper
• [Prognostic value of E-cadherina, beta catenin, Ki-67 antigen and p53 protein in the superficial bladder tumors].

  2006cites this paper
• Cadherina E, Catenina Beta, Antígeno Ki-67 y proteína p53 en el pronóstico de la recidiva tumoral en los tumores superficiales de vejiga T1

  2006cites this paper
• Chapter 14 – Immunohistology of the Prostate, Bladder, Testis and Kidney

  2006cites this paper
• The significance of p53 and bcl-2 overexpression and other prognostic factors in transitional cell carcinoma of the bladder

  2005cites this paper
• Molekulare Prognosemarker des Harnblasenkarzinoms

  2005cites this paper
• P53 as a prognostic marker for bladder cancer: a meta-analysis and review.

  2005cites this paper
• [Comparative study of the expression of p53, Ki-67, bcl-2 and CK20 in superficial transitional carcinoma of the bladder: correlation with recurrence, histological grade, and clinical stage].

  2003cites this paper
• Molecular pathology of non-invasive urothelial carcinomas (part I)

  2003cites this paper
• Estudio comparativo de la expresión de p53, Ki67, bcl-2 y CK20 en el carcinoma transicional superficial de vejiga: correlación con la recurrencia, grado histológico y estadio clínico

  2003cites this paper
• Immunohistochemical Study of bcl-2, p53 and Ki-67 Expressions in Collecting Duct Carcinoma of the Kidney

  2002cites this paper
• Histogenesis of nonurothelial carcinomas of the urinary bladder from pre-existent transitional cell carcinomas. A histopathological and immunohistochemical study

  2002cites this paper
• [Usefulness of p53 in the clinical management of bladder tumors].

  2001cites this paper
• [DNA ploidy determination with flow cytometry, Ki-67 index and overexpression of p53 protein in 121 T1 superficial bladder carcinomas. Retrospective studies. Part II: Prognostic value and usefulness in the indication for prophylactic treatment with BCG].

  2001cites this paper
• p53 protein expression and proliferative activity in imprints of superficial transitional cell carcinoma of the bladder.

  2000cites this paper
• p53 immunohistochemistry in bladder cancer. Combined analysis: a way to go?

  2000cites this paper
• Allelic losses demonstrate monoclonality of multifocal bladder tumors

  2000cites this paper
• [Molecular biology in bladder cancer].

  2000cites this paper
• Relationship between p53 gene mutation and protein expression: clinical significance in transitional cell carcinoma of the bladder.

  2000cites this paper
• DNA ploidy and p53 protein expression in superficial transitional cell carcinoma of the bladder

  2000cites this paper
• Serum Anti–p53 Antibodies and p53 Protein Status in the Sera and Tumors from Bladder Cancer Patients

  2000cites this paper
• p53 Expression Predicts Progression and Poor Survival in T1 Bladder Tumours

  2000cites this paper
• Mutation of cell cycle regulators and their impact on superficial bladder cancer.

  2000cites this paper
• Genetic alterations and biological pathways in human bladder cancer pathogenesis.

  2000cites this paper
• [DNA ploidy determination with flow cytometry, Ki-67 index, and overexpression of p53 protein in 121 T1 superficial bladder carcinoma. Retrospective study. Correlation with classic variables].

  2000cites this paper
• Expression of p53 and pRb in bladder and prostate cancers of patients having both cancers.

  1999cites this paper
• Low-frequency mutation of Ha-ras and Ki-ras oncogenes in transitional cell carcinoma of the bladder.

  1998cites this paper
• Interleukin-8 expression in the urine after bacillus Calmette-Guerin therapy: a potential prognostic factor of tumor recurrence and progression.

  1997cites this paper